Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page
- Check5 days agoChange DetectedA new revision v3.4.3 was added and the previous revision v3.4.2 was deleted from the record history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.4.2 was added to the record history; the government funding notice and the v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the revision version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check48 days agoChange DetectedUI updates include showing a glossary toggle, enabling green highlights for additions and red highlights for deletions, and updating the revision label to v3.4.0, with a capitalization change from 'No FEAR Act data' to 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedThe record history gains a new revision entry v3.3.4 and removes the previous entry v3.3.3.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.3%

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.